ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.431,82
0,14%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) News

ORGS

Orgenesis (ORGS)

Orgenesis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ORGS
DatumZeitQuelleÜberschriftSymbolFirma
06/06/202422h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORGSOrgenesis Inc
04/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORGSOrgenesis Inc
31/05/202412h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
24/05/202415h16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ORGSOrgenesis Inc
23/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
21/05/202413h00GlobeNewswire Inc.Orgenesis Provides Business Update for the First Quarter of 2024NASDAQ:ORGSOrgenesis Inc
20/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
15/05/202422h01Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ORGSOrgenesis Inc
06/05/202421h30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORGSOrgenesis Inc
06/05/202421h28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ORGSOrgenesis Inc
06/05/202421h26Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORGSOrgenesis Inc
15/04/202423h07GlobeNewswire Inc.Orgenesis Provides Year End Business UpdateNASDAQ:ORGSOrgenesis Inc
10/04/202418h00GlobeNewswire Inc.Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityNASDAQ:ORGSOrgenesis Inc
18/03/202413h30GlobeNewswire Inc.Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe ConferenceNASDAQ:ORGSOrgenesis Inc
13/03/202413h30GlobeNewswire Inc.Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic ExosomesNASDAQ:ORGSOrgenesis Inc
04/03/202414h30GlobeNewswire Inc.Orgenesis Inc. Announces $2.3 Million Private PlacementNASDAQ:ORGSOrgenesis Inc
29/02/202414h30GlobeNewswire Inc.Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP ManufacturingNASDAQ:ORGSOrgenesis Inc
31/01/202415h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
31/01/202415h15GlobeNewswire Inc.Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to ClinicNASDAQ:ORGSOrgenesis Inc
24/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
22/01/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
08/01/202423h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
08/01/202423h36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
05/01/202412h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
14/11/202314h30GlobeNewswire Inc.Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMNASDAQ:ORGSOrgenesis Inc
13/11/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
13/11/202322h15GlobeNewswire Inc.Orgenesis Provides Business Update for the Third Quarter of 2023NASDAQ:ORGSOrgenesis Inc
09/11/202313h41Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ORGSOrgenesis Inc
08/11/202315h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
08/11/202315h00GlobeNewswire Inc.Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct OfferingNASDAQ:ORGSOrgenesis Inc
 Showing the most relevant articles for your search:NASDAQ:ORGS

Kürzlich von Ihnen besucht

EU
H777S
H777S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten